Phreesia, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHR research report →
Range $10 – $16
Price Chart
About the company
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing.
- CEO
- Chaim Indig
- IPO
- 2019
- Employees
- 1,789
- HQ
- Wilmington, DE, US
Get TickerSpark's AI analysis on PHR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $639.13M
- P/E
- 60.05
- Fwd P/E
- 34.57
- PEG
- -0.19
- P/S
- 1.26
- P/B
- 1.72
- EV/EBITDA
- 11.26
- Div Yield
- 0.00%
- Gross Margin
- 63.55%
- Op Margin
- 3.19%
- Net Margin
- 2.06%
- ROE
- 3.01%
- ROIC
- 3.18%
Latest fiscal year · YoY change
- Revenue
- $480.59M+14.5%
- Gross Profit
- $326.47M+14.6%
- Op Income
- $-6,612,000
- Net Income
- $2.31M+103.9%
- EPS
- $0.04+103.8%
- OCF Growth
- +143.4%
- FCF Growth
- +716.6%
- 52W High
- $24.25
- 52W Low
- $7.77
- 50D MA
- $11.07
- 200D MA
- $11.42
- Beta
- 0.84
- RSI (14)
- 47
- Avg Volume
- 746.36K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Phreesia delivered Q2 fiscal 2027 revenue growth and expanding profitability, while reiterating full-year guidance and pointing to early traction in AccessOne and Network Solutions.· September 2, 2026
- Revenue rose 10% year over year to $129.5 million, with adjusted EBITDA of $32.9 million and margin of 25%.
- Net income was $1.9 million, Phreesia’s fifth straight quarter of positive net income.
- Client growth remained steady: average healthcare services clients were 4,744, up 277 year over year, and total revenue per AHSC was $27,289, up 4%.
- Cash generation stayed strong with $18.3 million of operating cash flow and $13.8 million of free cash flow, and the company reduced debt principal by over $23 million.
- Management maintained fiscal 2027 guidance for revenue of $510 million to $520 million and adjusted EBITDA of $125 million to $135 million.
Second-quarter revenue was $129.5 million, up 10% year over year. Adjusted EBITDA was $32.9 million, up $10.8 million year over year, with adjusted EBITDA margin of 25%. Net income was $1.9 million versus $700,000 a year ago, marking the fifth consecutive quarter of positive net income. Average healthcare services clients were 4,744, up 36 sequentially and 277 year over year; total revenue per AHSC was $27,289, up 4% year over year. Total managed payments were $1.626 billion and Payment Solutions revenue rate was 2.4%. Operating cash flow was $18.3 million and free cash flow was $13.8 million, both up year over year, and cash, cash equivalents and restricted cash ended at $74.6 million. For fiscal 2027, Phreesia kept revenue guidance at $510 million to $520 million and adjusted EBITDA guidance at $125 million to $135 million; the revenue outlook assumes about $37 million from AccessOne and no additional revenue from future acquisitions completed before January 31, 2027.
Chaim Indig said the company delivered a solid quarter with revenue growth and profitability expansion in line with expectations, and highlighted positive operating and free cash flow plus debt reduction. Strategically, he emphasized Phreesia’s broad product set, AccessOne as an extension of its value proposition, and Provider Connect as a newer Network Solutions offering with building momentum. He was notably upbeat on AI, saying it has changed the playing field and made him more excited about Phreesia’s future than at any point in the company’s history.
Balaji Gandhi walked through the quarter’s financial performance, highlighting 10% revenue growth to $129.5 million, adjusted EBITDA of $32.9 million, and 25% margin. He noted operating cash flow of $18.3 million, free cash flow of $13.8 million, and cash of $74.6 million at quarter end, with debt principal reduced by over $23 million. On outlook, he reaffirmed fiscal 2027 revenue of $510 million to $520 million and adjusted EBITDA of $125 million to $135 million, while keeping AHSC growth expectations in the mid-single-digit range and total revenue per AHSC growth in the low-single-digit range.
Analysts focused on AccessOne adoption, Network Solutions visibility, subscription pricing, AI opportunities, and the sustainability of EBITDA guidance. Management said AccessOne is seeing early wins and positive client feedback, with the acquisition now feeling better than at close, while Network Solutions has made progress in the second half and products like Provider Connect are resonating. On pricing and revenue mix, management said they are focused on total revenue and total revenue per client rather than one line item, and they kept EBITDA guidance unchanged because of prudent expense management, revenue mix sensitivity, and the early stage of AI deployment.
The call showed steady core execution: revenue, client counts, and profitability all improved, and cash generation remained strong. Management also described early traction in AccessOne and Network Solutions, said Provider Connect is resonating, and sounded highly optimistic about AI-driven product expansion and future growth.
Management still described parts of the outlook as mixed, especially the sensitivity around revenue mix and the lack of clean visibility in Network Solutions. They also acknowledged pressure on providers from payer changes, continued competition in check-in management, and only early-stage traction for newer initiatives like AccessOne, which may take time to scale.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 79.8%
- Shares Outstanding
- 61.81M
- Float Shares
- 49.35M
of shares held by institutions
254 13F filers
Buy/sell ratio 1.25. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for PHR, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Sell | Aug 26, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Aug 25, 26 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Sell | Mar 5, 26 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Oct 9, 25 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Buy | Oct 16, 23 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Sell | Sep 15, 23 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Buy | Dec 15, 21 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Sell | Dec 23, 20 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Sell | Dec 21, 20 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Oct 27, 20 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Sep 29, 20 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Apr 23, 20 | Filing → |
| Josh S. GottheimerHouse · NJ05 | Buy | Feb 3, 20 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Feb 10, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Pale Fire Capital Se | 8.92M | ▲ 275.00K |
| Blackrock, Inc. | 7.02M | ▲ 1.10M |
| Vanguard Group Inc | 5.74M | ▲ 39.54K |
| Aqr Capital Management LLC | 3.15M | ▲ 1.30M |
| Vanguard Portfolio Management LLC | 2.99M | ▼ 347.21K |
| Vanguard Capital Management LLC | 2.55M | ▲ 69.72K |
| Acadian Asset Management LLC | 1.60M | ▲ 576.57K |
| State Street Corp | 1.58M | ▲ 103.52K |
| Goldman Sachs Group Inc | 1.44M | ▲ 404.50K |
| Geode Capital Management, LLC | 1.31M | ▼ 59.74K |
| T. Rowe Price Investment Management, Inc. | 1.30M | ▲ 1.30M |
| Algert Global LLC | 1.21M | ▼ 175.39K |
Held by 225 ETFs
Biggest fund positions in PHR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 1, 26 | VanDuyn Amy Beth | other | 67,500 |
| Sep 1, 26 | Roberts Evan | other | 155,000 |
| Sep 1, 26 | Linetsky David | other | 155,000 |
| Sep 1, 26 | Indig Chaim | other | 400,000 |
| Sep 1, 26 | Hui Yvonne | other | 28,500 |
| Sep 1, 26 | Hoffman Allison C | other | 85,000 |
| Sep 1, 26 | Gandhi Balaji | other | 155,000 |
| Sep 18, 26 | VanDuyn Amy Beth | other | 2,876 |
| Sep 18, 26 | Roberts Evan | other | 4,476 |
| Sep 18, 26 | Linetsky David | other | 4,475 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PHR coverage
Recent articles, reports, and earnings notes.
No research on PHR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHR report →Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies
businesswire.com · Sep 30
Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock
defenseworld.net · Sep 23
Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
businesswire.com · Sep 14
Why Phreesia Stock Got Knocked Down Today
fool.com · Sep 8
Why Phreesia Stock Tumbled Today
fool.com · Sep 3
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
benzinga.com · Sep 3
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
seekingalpha.com · Sep 2
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Sep 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.